Amphastar Pharmaceuticals Investor Relations Material

Amphastar Pharmaceuticals, Inc. develops, manufactures and markets generic products and proprietary injectable, inhalation and intranasal products in the United States, China and France. The Company's primary product lines include generic versions of human pharmaceutical drugs primarily used in hospital operating rooms and intensive care units; diabetology solutions including insulin syringes and insulin pen needles; generic inhalation solutions for critical care settings such as anesthesia machines, ventilators and peak flow meters; and injection products used primarily in cardiac cath labs throughout Europe.